AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Neuren Pharmaceuticals Limited

$16.1 +$3.19 (+24.71%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$16.1
Day Range
$15.51$16.1
Year Range
$7.7$17.25
Market Cap
2.04B
AVG Volume
497
Trailing/Forward PE
130.83/26.76
PEG ratio
2.12
Dividend Yield
-
Next Earnings Date
2027-02-24
Primary Exchange
Other OTCUS
Revenue (AUD)
050M100M150M200M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
NURPF Revenue (AUD) by quarter
PeriodRevenue (AUD)
26 Q233.11M
25 Q436.34M
25 Q228.28M
24 Q4192.5M
24 Q224.33M
23 Q4169M
23 Q262.93M
22 Q414.55M
22 Q20
21 Q43.2M
Net Income (AUD)
-50M050M100M150M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
NURPF Net Income (AUD) by quarter
PeriodNet Income (AUD)
26 Q24.85M
25 Q415.4M
25 Q215.03M
24 Q4134.03M
24 Q28.02M
23 Q4109.28M
23 Q247.8M
22 Q47.24M
22 Q2-7.05M
21 Q4170K
Operating Income (AUD)
-50M050M100M150M200M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
NURPF Operating Income (AUD) by quarter
PeriodOperating Income (AUD)
26 Q22.72M
25 Q411.12M
25 Q2-4M
24 Q4160.02M
24 Q2-13.82M
23 Q4136.09M
23 Q248.14M
22 Q45.74M
22 Q2-7.34M
21 Q4-3.23M
EBITDA (AUD)
-50M050M100M150M200M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
NURPF EBITDA (AUD) by quarter
PeriodEBITDA (AUD)
26 Q22.73M
25 Q411.13M
25 Q210.91M
24 Q4175.11M
24 Q24.08M
23 Q4151.1M
23 Q248.15M
22 Q46.38M
22 Q2-7.33M
21 Q4-3.02M
Cash Flows (AUD)
-50M050M100M150M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
NURPF Cash Flows (AUD) by quarter
PeriodCash Flows (AUD)
26 Q27.98M
25 Q4-2.91M
25 Q2128.3M
24 Q49.26M
24 Q2-20.54M
23 Q4140.03M
23 Q244.86M
22 Q49.41M
22 Q2-5.83M
21 Q4-3.83M
EPS (AUD)
-0.500.511.521 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
NURPF EPS (AUD) by quarter
PeriodEPS (AUD)
26 Q20.04
25 Q40.12
25 Q20.12
24 Q41.03
24 Q20.06
23 Q40.83
23 Q20.37
22 Q40.06
22 Q2-0.06
21 Q40
Expenses (AUD)
010M20M30M40MR&DSG&ACapex21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
NURPF Expenses (AUD) by quarter
PeriodExpenses (AUD)
26 Q230.39M
25 Q425.24M
25 Q217.39M
24 Q417.41M
24 Q220.27M
23 Q417.93M
23 Q214.79M
22 Q48.81M
22 Q27.34M
21 Q43.23M
Cash & Debt (AUD)
0100M200M300MCashLong Term DebtShort Term Debt21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
NURPF Cash & Debt (AUD) by quarter
PeriodCash & Debt (AUD)
26 Q2286.14M
25 Q4296.01M
25 Q2299.54M
24 Q4222.24M
24 Q2213.17M
23 Q4228.54M
23 Q285.67M
22 Q440.18M
22 Q231.09M
21 Q436.78M
Debt ratios
-202421 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
NURPF Debt ratios by quarter
PeriodDebt ratios
26 Q2-1.43
25 Q4-1.47
25 Q2-0.88
24 Q4-0.59
24 Q2-1.02
23 Q4-1.15
23 Q2-1.94
22 Q43.3
22 Q21.31
21 Q41.7
Margins
0%25%50%75%100%20 Q421 Q422 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
NURPF Margins by quarter
PeriodMargins
26 Q299.96%
25 Q499.97%
25 Q247.32%
24 Q492.17%
24 Q226.46%
23 Q490.73%
23 Q282.38%
22 Q499.96%
21 Q499.87%
20 Q499.58%
Return on Capital
-40%-20%0%20%40%60%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
NURPF Return on Capital by quarter
PeriodReturn on Capital
26 Q21.46%
25 Q44.55%
25 Q24.65%
24 Q436.83%
24 Q23.66%
23 Q453.25%
23 Q252.24%
22 Q417.4%
22 Q2-21.06%
21 Q40.43%
Shares Outstanding
050M100M150M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
NURPF Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2126.77M
25 Q4126.64M
25 Q2128.99M
24 Q4130.75M
24 Q2127.67M
23 Q4127.27M
23 Q2126.34M
22 Q4125.97M
22 Q2125.97M
21 Q4128.97M
Dividends (AUD)
00.511.5Sep 26
NURPF Dividends (AUD) by quarter
PeriodDividends (AUD)
Sep 260.11
Book Value Per Share (AUD)
012321 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
NURPF Book Value Per Share (AUD) by quarter
PeriodBook Value Per Share (AUD)
26 Q22.63
25 Q42.67
25 Q22.51
24 Q42.78
24 Q21.72
23 Q41.61
23 Q20.72
22 Q40.33
22 Q20.27
21 Q40.3
Total Assets (AUD)
0200M400M600M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
NURPF Total Assets (AUD) by quarter
PeriodTotal Assets (AUD)
26 Q2340.15M
25 Q4342.72M
25 Q2331.25M
24 Q4409.71M
24 Q2228.15M
23 Q4247.97M
23 Q297.52M
22 Q443.27M
22 Q234.59M
21 Q440.06M
PE Ratio
05101520med 9.06Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NURPF PE Ratio by quarter
PeriodPE Ratio
Sep 2616.37
Sep 2616.41
Aug 2616.65
Aug 2615.87
Aug 2617.62
Aug 2615.58
Jul 2614.07
Jul 2614.15
Jul 2614.15
Jul 2614.21
Jul 2614.28
Jun 269.32
Jun 269.09
Jun 269.25
Jun 269.25
May 269.07
May 269.15
May 269.12
May 268.93
May 268.99
Apr 269.06
Apr 269.03
Apr 268.55
Apr 268.74
Mar 265.79
Mar 265.67
Mar 265.91
Mar 265.87
Feb 265.8
Feb 266.73
Feb 266.74
Feb 266.07
Jan 268.36
Jan 269.07
Jan 269.35
Jan 269.35
Jan 269.34
Dec 259.29
Dec 259.44
Dec 259.38
Dec 259.4
Nov 259.05
Nov 259.19
Nov 259.08
Nov 259.62
Oct 259.87
Oct 258.79
Oct 258.81
Oct 2511.07
Oct 2510.85
Sep 258.01
Sep 258.64
Sep 258.93
Sep 258.49
Aug 258.5
Aug 257.39
Aug 258.25
Aug 257.37
Aug 257.43
Jul 257.32
Jul 256.77
Jul 255.97
Jul 255.86
Jun 255.89
Jun 255.97
Jun 255.97
Jun 255.96
May 255.55
May 255.5
May 255.56
May 255.59
May 255.43
Apr 254.95
Apr 255.02
Apr 255.3
Apr 255.52
Mar 258.08
Mar 258.1
Mar 258.49
Mar 259.11
Feb 2510.25
Feb 259.5
Feb 259.74
Feb 2510.46
Jan 2510.56
Jan 259.11
Jan 259.28
Jan 259.35
Jan 259.25
Dec 249.38
Dec 249.32
Dec 249.31
Dec 249.27
Nov 249.04
Nov 249.06
Nov 2410.88
Nov 2410.69
Nov 2410.13
Oct 249.88
Oct 247.54
Free Cash Flow Yield
0%5%10%15%20%med 9.99%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NURPF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 264.04%
Sep 264.03%
Aug 263.97%
Aug 264.17%
Aug 263.76%
Aug 264.25%
Jul 264.7%
Jul 264.67%
Jul 264.68%
Jul 264.66%
Jul 264.63%
Jun 267.1%
Jun 267.28%
Jun 267.15%
Jun 267.15%
May 267.29%
May 267.23%
May 267.26%
May 267.41%
May 267.36%
Apr 267.31%
Apr 267.32%
Apr 267.74%
Apr 267.57%
Mar 2616.66%
Mar 2617.03%
Mar 2616.33%
Mar 2616.45%
Feb 2616.65%
Feb 2614.33%
Feb 2614.31%
Feb 2615.89%
Jan 2611.55%
Jan 2610.65%
Jan 2610.32%
Jan 2610.33%
Jan 2610.34%
Dec 2510.39%
Dec 2510.22%
Dec 2510.29%
Dec 2510.27%
Nov 2510.66%
Nov 2510.5%
Nov 2510.63%
Nov 2510.03%
Oct 259.77%
Oct 2510.98%
Oct 2510.95%
Oct 258.72%
Oct 258.89%
Sep 257.25%
Sep 256.72%
Sep 256.5%
Sep 256.84%
Aug 256.82%
Aug 257.86%
Aug 257.04%
Aug 257.88%
Aug 257.81%
Jul 257.93%
Jul 258.57%
Jul 259.72%
Jul 259.91%
Jun 259.85%
Jun 259.72%
Jun 259.73%
Jun 259.73%
May 2510.46%
May 2510.56%
May 2510.45%
May 2510.39%
May 2510.69%
Apr 2511.72%
Apr 2511.56%
Apr 2510.95%
Apr 2510.51%
Mar 2512.48%
Mar 2512.44%
Mar 2511.87%
Mar 2511.06%
Feb 259.83%
Feb 2510.61%
Feb 2510.35%
Feb 259.64%
Jan 259.54%
Jan 2511.07%
Jan 2510.86%
Jan 2510.78%
Jan 2510.9%
Dec 2410.75%
Dec 2410.81%
Dec 2410.83%
Dec 2410.87%
Nov 2411.15%
Nov 2411.13%
Nov 249.26%
Nov 249.43%
Nov 249.96%
Oct 2410.2%
Oct 2413.37%
Price to Sales
24681012med 5.67Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NURPF Price to Sales by quarter
PeriodPrice to Sales
Sep 2610.03
Sep 2610.05
Aug 2610.2
Aug 269.73
Aug 2610.79
Aug 269.55
Jul 268.62
Jul 268.67
Jul 268.67
Jul 268.71
Jul 268.75
Jun 265.71
Jun 265.57
Jun 265.67
Jun 265.67
May 265.56
May 265.6
May 265.59
May 265.47
May 265.51
Apr 265.55
Apr 265.54
Apr 265.24
Apr 265.35
Mar 263.73
Mar 263.65
Mar 263.8
Mar 263.77
Feb 263.73
Feb 264.33
Feb 264.34
Feb 263.91
Jan 265.38
Jan 265.83
Jan 266.02
Jan 266.01
Jan 266
Dec 255.98
Dec 256.07
Dec 256.03
Dec 256.05
Nov 255.82
Nov 255.91
Nov 255.84
Nov 256.19
Oct 256.35
Oct 255.65
Oct 255.67
Oct 257.12
Oct 256.98
Sep 255.34
Sep 255.76
Sep 255.95
Sep 255.66
Aug 255.67
Aug 254.92
Aug 255.5
Aug 254.91
Aug 254.95
Jul 254.88
Jul 254.51
Jul 253.98
Jul 253.91
Jun 253.93
Jun 253.98
Jun 253.98
Jun 253.97
May 253.7
May 253.66
May 253.7
May 253.72
May 253.62
Apr 253.3
Apr 253.35
Apr 253.53
Apr 253.68
Mar 255.14
Mar 255.16
Mar 255.4
Mar 255.8
Feb 256.53
Feb 256.05
Feb 256.2
Feb 256.65
Jan 256.72
Jan 255.79
Jan 255.91
Jan 255.95
Jan 255.88
Dec 245.97
Dec 245.93
Dec 245.92
Dec 245.9
Nov 245.75
Nov 245.77
Nov 246.93
Nov 246.8
Nov 246.45
Oct 246.29
Oct 244.8
EV/EBITDA
051015med 6.3Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NURPF EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2612.56
Sep 2612.59
Aug 2612.8
Aug 2612.13
Aug 2613.63
Aug 2611.88
Jul 2610.59
Jul 2610.66
Jul 2610.66
Jul 2610.71
Jul 2610.77
Jun 266.51
Jun 266.32
Jun 266.46
Jun 266.46
May 266.31
May 266.37
May 266.34
May 266.19
May 266.23
Apr 266.29
Apr 266.27
Apr 265.85
Apr 266.02
Mar 263.64
Mar 263.55
Mar 263.74
Mar 263.7
Feb 263.65
Feb 264.38
Feb 264.39
Feb 263.86
Jan 265.65
Jan 266.2
Jan 266.42
Jan 266.42
Jan 266.41
Dec 256.38
Dec 256.49
Dec 256.44
Dec 256.46
Nov 256.19
Nov 256.29
Nov 256.21
Nov 256.64
Oct 256.83
Oct 255.98
Oct 256
Oct 257.76
Oct 257.6
Sep 255.74
Sep 256.24
Sep 256.47
Sep 256.12
Aug 256.13
Aug 255.25
Aug 255.93
Aug 255.24
Aug 255.28
Jul 255.2
Jul 254.76
Jul 254.13
Jul 254.04
Jun 254.07
Jun 254.13
Jun 254.13
Jun 254.13
May 253.8
May 253.76
May 253.8
May 253.83
May 253.7
Apr 253.33
Apr 253.38
Apr 253.6
Apr 253.78
Mar 255.62
Mar 255.64
Mar 255.96
Mar 256.47
Feb 257.41
Feb 256.79
Feb 256.99
Feb 257.58
Jan 257.66
Jan 256.47
Jan 256.61
Jan 256.67
Jan 256.58
Dec 246.69
Dec 246.65
Dec 246.63
Dec 246.6
Nov 246.41
Nov 246.43
Nov 247.93
Nov 247.77
Nov 247.31
Oct 247.1
Oct 245.18
Price/Operating Cashflow
0102030med 10.01Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NURPF Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2624.73
Sep 2624.79
Aug 2625.15
Aug 2623.98
Aug 2626.61
Aug 2623.54
Jul 2621.26
Jul 2621.38
Jul 2621.38
Jul 2621.47
Jul 2621.57
Jun 2614.07
Jun 2613.74
Jun 2613.98
Jun 2613.98
May 2613.71
May 2613.82
May 2613.77
May 2613.5
May 2613.58
Apr 2613.68
Apr 2613.65
Apr 2612.91
Apr 2613.2
Mar 266
Mar 265.87
Mar 266.12
Mar 266.08
Feb 266.01
Feb 266.98
Feb 266.99
Feb 266.29
Jan 268.66
Jan 269.39
Jan 269.69
Jan 269.68
Jan 269.67
Dec 259.63
Dec 259.78
Dec 259.72
Dec 259.74
Nov 259.38
Nov 259.52
Nov 259.4
Nov 259.97
Oct 2510.23
Oct 259.1
Oct 259.13
Oct 2511.46
Oct 2511.25
Sep 2513.8
Sep 2514.87
Sep 2515.38
Sep 2514.63
Aug 2514.65
Aug 2512.72
Aug 2514.2
Aug 2512.69
Aug 2512.8
Jul 2512.61
Jul 2511.66
Jul 2510.29
Jul 2510.09
Jun 2510.15
Jun 2510.28
Jun 2510.28
Jun 2510.27
May 259.56
May 259.47
May 259.57
May 259.62
May 259.35
Apr 258.53
Apr 258.65
Apr 259.13
Apr 259.51
Mar 258.01
Mar 258.03
Mar 258.42
Mar 259.04
Feb 2510.17
Feb 259.42
Feb 259.66
Feb 2510.37
Jan 2510.47
Jan 259.03
Jan 259.21
Jan 259.27
Jan 259.17
Dec 249.3
Dec 249.25
Dec 249.23
Dec 249.2
Nov 248.96
Nov 248.98
Nov 2410.79
Nov 2410.6
Nov 2410.04
Oct 249.8
Oct 247.48
Price to Book
46810med 7.04Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NURPF Price to Book by quarter
PeriodPrice to Book
Sep 268.34
Sep 268.36
Aug 268.49
Aug 268.09
Aug 268.98
Aug 267.94
Jul 267.17
Jul 267.22
Jul 267.21
Jul 267.24
Jul 267.28
Jun 264.75
Jun 264.63
Jun 264.72
Jun 264.72
May 264.63
May 264.66
May 264.65
May 264.55
May 264.58
Apr 264.62
Apr 264.61
Apr 264.36
Apr 264.45
Mar 264.77
Mar 264.67
Mar 264.87
Mar 264.83
Feb 264.78
Feb 265.55
Feb 265.56
Feb 265
Jan 266.89
Jan 267.47
Jan 267.71
Jan 267.7
Jan 267.69
Dec 257.66
Dec 257.78
Dec 257.73
Dec 257.74
Nov 257.46
Nov 257.57
Nov 257.48
Nov 257.93
Oct 258.14
Oct 257.24
Oct 257.26
Oct 259.12
Oct 258.94
Sep 256.58
Sep 257.1
Sep 257.34
Sep 256.98
Aug 256.99
Aug 256.07
Aug 256.78
Aug 256.06
Aug 256.11
Jul 256.02
Jul 255.56
Jul 254.91
Jul 254.82
Jun 254.84
Jun 254.91
Jun 254.9
Jun 254.9
May 254.56
May 254.52
May 254.57
May 254.59
May 254.46
Apr 254.07
Apr 254.13
Apr 254.36
Apr 254.54
Mar 256.35
Mar 256.37
Mar 256.68
Mar 257.17
Feb 258.06
Feb 257.47
Feb 257.66
Feb 258.22
Jan 258.31
Jan 257.16
Jan 257.3
Jan 257.35
Jan 257.27
Dec 247.37
Dec 247.33
Dec 247.32
Dec 247.29
Nov 247.11
Nov 247.12
Nov 248.56
Nov 248.41
Nov 247.96
Oct 247.77
Oct 245.93
Neuren Pharmaceuticals Limited
NURPF
Stockpicker

Video analysis: NURPF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NURPF

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.